Paloma Partners Management CO Windtree Therapeutics Inc Transaction History

Paloma Partners Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.14 - $6.18 $39,523 - $114,138	-18,469 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.98 - $7.47 $92,732 - $139,098	-18,621 Reduced 50.2%	18,469 $95,000
Q3 2020 Nov 16, 2020	BUY	$5.5 - $9.9 $203,995 - $367,191	37,090 New	37,090 $204,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $34M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.